Ca2+-dependence of vasoconstriction mediated by α(1A)-adrenoceptors in perfused rat hindlimb: A pharmacological approach

Life Sciences

Volumn 63, Issue 5, 1998, Pages PL89-PL94

  Zhu, Wei Zhong ^b   Kwan, Chiu Yin ^a   Chide, Han ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Ca2+ channels; Ca2+ stores; Hindlimb vasculature; Rat; 1 adrenoceptor

Indexed keywords

ALPHA 1A ADRENERGIC RECEPTOR; CADMIUM CHLORIDE; CAFFEINE; CALCIUM ION; CYCLOPIAZONIC ACID; DESIPRAMINE; INDOMETACIN; NIFEDIPINE; NORADRENALIN; NORMETADRENALIN; PRAZOSIN; PROPRANOLOL; YOHIMBINE; ALPHA 1 ADRENERGIC RECEPTOR; CALCIUM; CALCIUM CHANNEL; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL REACTIVITY; CALCIUM MOBILIZATION; CONTROLLED STUDY; HINDLIMB; LIMB BLOOD FLOW; LIMB PERFUSION; MALE; NONHUMAN; RAT; REGIONAL PERFUSION; VASOCONSTRICTION; ANIMAL; DRUG EFFECT; METABOLISM; PERFUSION; PHYSIOLOGY; VASCULAR SMOOTH MUSCLE; VASCULARIZATION; WISTAR RAT;

ANIMALIA;

ANIMALS; CAFFEINE; CALCIUM; CALCIUM CHANNELS; HINDLIMB; MALE; MUSCLE, SMOOTH, VASCULAR; NIFEDIPINE; NOREPINEPHRINE; PERFUSION; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-1; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0031603669     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0024-3205(98)00290-2     Document Type: Article

References (17)

1. 1. G. DROOGMANS, L. RAEYMAEKER, and R. CASTEELS. J. Gen. Physiol. 70 129-148 (1977).
2. 2. M.T. NELSON, N.B. STANDEN, J.E. BRAYDEN and J.F. WORLEY. Nature 336 382-385 (1988).
3. 3. C. CAUVIN, O. HWANG, M. YAMAMOTO and C. VAN BREEMAN. Am J Cardiol 59 116B-122B (1987)
4. 4. R.K. HESTER. J. Pharmacol. .Exp. Ther. 247 223-234 (1988).
5. 5. C. VAN BREEMEN and K. SAIDA. Annu. Rev. Physiol. 51 315-329 (1989).
6. 6. A.M. LOW, N. KOTECHA, T.O. NEILD, C.Y. KWAN and E.E. DANIEL. Clin. Exp. Phaarmacol Physiol. 23 310-316 (1996).
7. 7. V.A. GOLOVINA and M.P. BLAUSTEIN. Science 275 1643-1648 (1997).
8. 8. B.E. EHRLICH, E. KAFTAN, S. BEZPROZVANNAYA and I. BEZPROZVANNYA. Trends Pharmacol. Sci. 15145-149 (1994).
9. 9. Y.Y. GUAN, C.Y. KWAN and E.E. DANIEL. Can. J. Physiol. Pharmacol. 67 1086-1091 (1989).
10. 10. R.M. GRAHAM, D.M. PEREZ, J. HWA and M. PIASCIK. Cir. Res. 78 737-749 (1996).
11. 11. C. HAN, P.W. ABEL and K.P. MINNEMAN. Nature 329 333-335 (1987).
12. 12. L. TAO, Y.Y. GUAN, H. He, C. HAN, Y.Y. Zhang and J.J. Sun. ife Sci. 61 2127-2136 (1997).
13. 13. C. HAN, J. LI and M.P. MINNEMAN. Eur. J. Pharmacol. 190 97-104 (1990).
14. 14. W.Z. ZHU, Y.Y. ZHANG and C. HAN. Eur. J. Pharmacol. 329 55-61 (1997).
15. 15. E.Q. COQUUHOUN, M. HETTIARACHCHI, J.M. YE, S. RATIGEN and M.G. CLARK. General Pharmacol. 21 141-148 (1990).
16. 16. C.Y. KWAN, R. CHAUDHARY, X.F. ZHENG, J. NI and R.M.K.W. LEE. Hypertension 23(suppl I) I-156-I-160 (1994).
17. 17. X.F. ZHENG, C.Y. KWAN and E.E. DANIEL. J Vas Res 31 18-24 (1994).